Single Dose Methotrexate in Treatment of Ectopic Pregnancy: Review of 32 Case
dc.authorwosid | SAYIN, N. CENK/A-5801-2018 | |
dc.contributor.author | Aybatli, Aysun | |
dc.contributor.author | Kaplan, Petek Balkanli | |
dc.contributor.author | Alicik, Mehmet | |
dc.contributor.author | Sayin, Niyazi Cenk | |
dc.contributor.author | Yuce, Mehmet Ali | |
dc.date.accessioned | 2024-06-12T11:00:01Z | |
dc.date.available | 2024-06-12T11:00:01Z | |
dc.date.issued | 2011 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 6th Congress of Gynecology and Obstetrics -- MAY 14-19, 2008 -- Antalya, TURKEY | en_US |
dc.description.abstract | Objective: To evaluate the efficacy of single dose intramuscular methotrexate in the treatment of ectopic pregnancy. Material and Methods: 32 patients who matched the inclusion criteria were enrolled. Success of treatment was defined as a resolution of ectopic pregnancy without performing surgical intervention. The cases in whom the treatment was successful and those that were not were compared for beta-hCG values and clinical features. Results: beta-hCG at diagnosis averaged 1293.9 mlU/ml. Of the 32 patients who received methotrexate, 26 were successfully treated. 23 patients (71.8%) received a single dose of methotrexate, 3 patients (9.3%) received an additional dose of methotrexate, 6 patients (18.7%) who had failed methotrexate required surgery for cure. The success rate of single-dose methotrexate was 79.3%. Conclusion: Our study shows that single dose systemic methotrexate treatment can be used as an option in unruptured pregnancies. | en_US |
dc.identifier.doi | 10.5174/tutfd.2009.02161.1 | |
dc.identifier.endpage | 13 | en_US |
dc.identifier.issn | 2146-3123 | |
dc.identifier.issn | 2146-3131 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-79959670752 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 10 | en_US |
dc.identifier.uri | https://doi.org/10.5174/tutfd.2009.02161.1 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20673 | |
dc.identifier.volume | 28 | en_US |
dc.identifier.wos | WOS:000293059800003 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.relation.ispartof | Balkan Medical Journal | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Ectopic Pregnancy | en_US |
dc.subject | Methotrexate | en_US |
dc.subject | Beta-Hcg | en_US |
dc.subject | Single Dose | en_US |
dc.subject | Medical-Management | en_US |
dc.subject | Failure | en_US |
dc.title | Single Dose Methotrexate in Treatment of Ectopic Pregnancy: Review of 32 Case | en_US |
dc.type | Conference Object | en_US |